Wardwizard Healthcare shareholders approve all nine AGM resolutions

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • All nine resolutions passed with 100% votes in favor
  • Overall voting participation reached 89.99% of outstanding shares
  • M/s MGSA & Company appointed as statutory auditors for five years
  • Related party transaction vote saw 15.91% participation due to promoter exclusion
powered bylight_fuzz_icon
52668502

*this image is generated using AI for illustrative purposes only.

Wardwizard Healthcare Limited shareholders voted in favor of all nine resolutions proposed at the 42nd Annual General Meeting (AGM), held on September 30, 2026. The meeting, conducted via video conferencing, saw a high turnout with 89.99% of outstanding shares participating in the voting process.

The scrutinizer's report confirmed that every resolution received 100% of votes cast in favor. Key approvals included the adoption of standalone audited financial statements for FY26, the reappointment of director Yatin Sanjay Gupta, and the appointment of M/s MGSA & Company as statutory auditors for a five-year term.

Voting Participation and Attendance

The AGM recorded attendance from nine equity shareholders through video conferencing. The voting rights were exercised by members holding shares as on the cut-off date of September 21, 2026. Remote e-voting was open from September 27 to September 29, 2026.

Category Shares Held Votes Polled % of Outstanding Votes For Votes Against
Promoter and Promoter Group 1,81,500 1,81,500 100.00% 1,81,500 0
Public - Non Institutions 63,500 38,981 61.39% 38,981 0
Total 2,45,000 2,20,481 89.99% 2,20,481 0

Key Resolutions Approved

Shareholders approved several significant corporate actions, including governance changes and capital structure adjustments:

  • Adoption of Financial Statements: Standalone audited financial statements for the year ended March 31, 2026 were adopted.
  • Director Appointments: Yatin Sanjay Gupta was reappointed as a director liable to retire by rotation. Mr. Yuvraj Priyadarshi was approved as Whole Time Director, and Ms. Sathi Kundu was appointed as Non-Executive Independent Director.
  • Auditor Appointment: M/s MGSA & Company was regularized and appointed as statutory auditor for five consecutive years, with remuneration fixed by the Board.
  • Capital Structure: An increase in authorized share capital and the issue of fully convertible warrants on a preferential basis were approved.

Related Party Transaction Approval

Resolution No. 9 pertained to material related party transactions between the company and Wardwizard Medicare Private Limited (WMPL). Notably, WMPL holds 27,932 equity shares but is classified as a related party. Consequently, their votes were excluded from the count for this specific resolution.

For this item, only public non-institutional shareholders participated. Out of 63,500 shares held by this category, 38,981 votes were polled, all in favor. The total valid votes cast for this resolution stood at 38,981, representing 15.91% of the company's total outstanding shares.

What the Numbers Show

The voting data reveals a stark contrast in participation levels between standard resolutions and those involving related parties. While overall voter turnout was robust at nearly 90%, the exclusion of promoter group votes in Resolution No. 9 reduced the effective voting base to just under 16% of outstanding shares. This highlights the significant influence of the promoter group (holding 74.08% of shares) on general corporate matters, while minority shareholders retain decisive power on related-party transactions where promoters are conflicted.

Historical Stock Returns for Wardwizard Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+139.89%

How will the approved preferential issue of fully convertible warrants impact Wardwizard Healthcare's shareholding pattern and future capital structure?

What specific strategic objectives or expansion plans are driving the increase in authorized share capital approved at the AGM?

How might the new governance structure, including the appointment of Ms. Sathi Kundu as Independent Director, influence oversight of related party transactions with WMPL?

like19
dislike

Wardwizard Healthcare clarifies ₹8 crore investment plan in AGM corrigendum

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Wardwizard Healthcare issued an AGM corrigendum on September 19, 2026, clarifying preferential issue objects
  • ₹8 crore in proceeds will be invested exclusively in Wardwizard Medicare Private Limited
  • Funds will subscribe to 2% Non-Cumulative Convertible Preference Shares for hospital expansion
  • Company confirmed no proceeds will repay loans or obligations of promoter group entities
  • The 42nd AGM is scheduled for September 30, 2026, via VC/OAVM
powered bylight_fuzz_icon
51370046

*this image is generated using AI for illustrative purposes only.

Wardwizard Healthcare Limited issued a corrigendum to its 42nd Annual General Meeting (AGM) notice on September 19, 2026. The update clarifies the utilization of proceeds from a proposed preferential issue of fully convertible warrants.

The company addressed a query from the Bombay Stock Exchange (BSE) dated September 17, 2026, by restating the object of the investment under Item No. 8 of the AGM Notice. This action ensures compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investment Details

The corrigendum specifies that the entire amount of ₹8 crore proposed for investment will be directed exclusively to Wardwizard Medicare Private Limited (WMPL). The funds will be utilized for subscribing to 2% Non-Cumulative Convertible Preference Shares.

Investment Parameter Detail
Investee Company Wardwizard Medicare Private Limited
Amount ₹8 crore
Instrument 2% Non-Cumulative Convertible Preference Shares
Purpose Growth and expansion of hospital business

WMPL currently operates four hospitals in Vadodara, Nadiad, Bharuch, and Dahej, along with one Ayurvedic Centre in Vadodara. The proposed capital infusion aims to support the growth, expansion, and development of these healthcare facilities.

Proceeds Utilization Restrictions

Wardwizard Healthcare explicitly confirmed that no portion of the preferential issue proceeds will be used for any other promoter or promoter group company. Furthermore, the funds will not be utilized, directly or indirectly, for the repayment of any loans, advances, financial assistance, dues, or other outstanding obligations of WMPL or any other related party.

This restriction covers obligations towards the company itself, its lenders, creditors, or other related parties. The utilization of proceeds remains subject to the Companies Act, 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws.

Meeting Logistics

The 42nd AGM is scheduled for September 30, 2026, at 3:00 pm through Video Conferencing or Other Audio-Visual Means (VC/OAVM). The corrigendum forms an integral part of the original AGM Notice dated August 31, 2026. Members will receive the updated notice electronically via National Depository Services Limited (NSDL).

Historical Stock Returns for Wardwizard Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+139.89%

How might the exclusive allocation of ₹8 crore to Wardwizard Medicare Private Limited impact the parent company's liquidity and future capital raising strategies?

What is the expected timeline for the conversion of the 2% Non-Cumulative Convertible Preference Shares, and how could this affect existing shareholders' equity dilution?

Given the strict prohibition on using proceeds for debt repayment, what specific operational metrics or expansion milestones must WMPL achieve to justify this capital infusion?

like20
dislike

More News on Wardwizard Healthcare

1 Year Returns:0.00%